National Institute of Mental Health (NIMH); Notice of Meeting, 70124-70125 [2016-24409]
Download as PDF
70124
Federal Register / Vol. 81, No. 196 / Tuesday, October 11, 2016 / Notices
Use’’ may send an email request to
CDRH-Guidance@fda.hhs.gov to receive
an electronic copy of the document.
Please use the document number 1755
to identify the guidance you are
requesting.
IV. Paperwork Reduction Act of 1995
This guidance refers to previously
approved collections of information
found in FDA regulations and guidance.
These collections of information are
subject to review by the Office of
Management and Budget (OMB) under
the Paperwork Reduction Act of 1995
(44 U.S.C. 3501–3520). The collections
of information in 21 CFR part 807
subpart E have been approved under
OMB control number 0910–0120; the
collections of information in 21 CFR 801
and 21 CFR 809.10 have been approved
under OMB control number 0910–0485;
the collections of information in 21 CFR
part 820 have been approved under
OMB control number 0910–0073; the
collections of information in the
guidance document ‘‘Recommendations:
Clinical Laboratory Improvement
Amendments of 1988 (CLIA) Waiver
Applications for Manufacturers of In
Vitro Diagnostic Devices’’ have been
approved under OMB control number
0910–0598; and the collections of
information in the guidance document
‘‘Requests for Feedback on Medical
Device Submissions: The PreSubmission Program and Meetings with
Food and Drug Administration Staff’’
have been approved under OMB control
number 0910–0756.
Dated: October 4, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016–24430 Filed 10–7–16; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
asabaliauskas on DSK3SPTVN1PROD with NOTICES
National Institute of Mental Health
(NIMH); Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of an Interagency Autism
Coordinating Committee (IACC or
Committee) meeting.
The purpose of the IACC meeting is
to discuss business, agency updates, and
issues related to autism spectrum
disorder (ASD) research and services
activities. The Committee will discuss
the 2016–2017 update of the IACC
Strategic Plan. The meeting will be open
VerDate Sep<11>2014
20:12 Oct 07, 2016
Jkt 241001
to the public and will be accessible by
webcast and conference call.
Name of Committee: Interagency Autism
Coordinating Committee (IACC).
Type of meeting: Open Meeting.
Date: October 26, 2016.
Time: 9:00 a.m. to 5:00 p.m.* Eastern Time
* Approximate end time.
Agenda: To discuss business, updates, and
issues related to ASD research and services
activities. The Committee will discuss
updates of the IACC Strategic Plan.
Place: National Institutes of Health , 31
Center Drive, Building 31, C Wing, 6th Floor,
Conference Room 6, Bethesda, MD 20892.
Webcast Live: https://videocast.nih.gov.
Conference Call Access: Dial: 888–469–
2037, Access code: 3353029.
Cost: The meeting is free and open to the
public.
Registration: A registration web link will
be posted on the IACC Web site
(www.iacc.hhs.gov) prior to the meeting. Preregistration is recommended to expedite
check-in. Seating in the meeting room is
limited to room capacity and on a first come,
first served basis. Onsite registration will also
be available.
Deadlines: Notification of intent to present
oral comments: Wednesday, October 12,
2016 by 5:00 p.m. ET.
Submission of written/electronic statement
for oral comments: Tuesday, October 18,
2016 by 5:00 p.m. ET.
Submission of written comments: Tuesday,
October 18, 2016 by 5:00 p.m. ET.
For IACC Public Comment guidelines
please see: https://iacc.hhs.gov/meetings/
public-comments/guidelines/.
Access: Medical Center Metro Station (Red
Line).
Contact Person: Ms. Angelice Mitrakas,
Office of Autism Research Coordination,
National Institute of Mental Health, NIH,
6001 Executive Boulevard, Room 6182A,
Bethesda, MD 20892–9669, Phone: 301–435–
9269, Email: IACCPublicInquiries@
mail.nih.gov.
Public Comments: Any member of the
public interested in presenting oral
comments to the Committee must notify
the Contact Person listed on this notice
by 5:00 p.m. ET on Wednesday, October
12, 2016, with their request to present
oral comments at the meeting, and a
written/electronic copy of the oral
presentation/statement must be
submitted by 5:00 p.m. ET on Tuesday,
October 18,
A limited number of slots for oral
comment are available, and in order to
ensure that as many different
individuals are able to present
throughout the year as possible, any
given individual only will be permitted
to present oral comments once per
calendar year (2016). Only one
representative of an organization will be
allowed to present oral comments in
any given meeting; other representatives
of the same group may provide written
comments. If the oral comment session
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
is full, individuals who could not be
accommodated are welcome to provide
written comments instead. Comments to
be read or presented in the meeting
must not exceed 250 words or 3
minutes, but a longer version may be
submitted in writing for the record.
Commenters going beyond the 250 word
or 3 minute time limit in the meeting
may be asked to conclude immediately
in order to allow other comments and
presentations to proceed on schedule.
Any interested person may submit
written public comments to the IACC
prior to the meeting by emailing the
comments to IACCPublicInquiries@
mail.nih.gov or by submitting comments
at the web link: https://iacc.hhs.gov/
meetings/public-comments/submit/
index.jsp by 5:00 p.m. ET on Tuesday,
October 18, 2016. The comments should
include the name, address, telephone
number, and when applicable, the
business or professional affiliation of
the interested person. NIMH anticipates
written public comments received by
5:00 p.m. ET on Tuesday, October 18,
2016 will be presented to the Committee
prior to the meeting for the Committee’s
consideration. Any written comments
received after the 5:00 p.m. ET, October
18, 2016 deadline through October 25,
2016 will be provided to the Committee
either before or after the meeting,
depending on the volume of comments
received and the time required to
process them in accordance with
privacy regulations and other applicable
Federal policies. All written public
comments and oral public comment
statements received by the deadlines for
both oral and written public comments
will be provided to the IACC for their
consideration and will become part of
the public record. Attachments of
copyrighted publications are not
permitted, but web links or citations for
any copyrighted works cited may be
provided.
In the 2009 IACC Strategic Plan, the
IACC listed the ‘‘Spirit of Collaboration’’
as one of its core values, stating that,
‘‘We will treat others with respect, listen
to diverse views with open minds,
discuss submitted public comments,
and foster discussions where
participants can comfortably offer
opposing opinions.’’ In keeping with
this core value, the IACC and the NIMH
Office of Autism Research Coordination
(OARC) ask that members of the public
who provide public comments or
participate in meetings of the IACC also
seek to treat others with respect and
consideration in their communications
and actions, even when discussing
issues of genuine concern or
disagreement.
E:\FR\FM\11OCN1.SGM
11OCN1
Federal Register / Vol. 81, No. 196 / Tuesday, October 11, 2016 / Notices
Remote Access: The meeting will be
open to the public through a conference
call phone number and webcast live on
the Internet. Members of the public who
participate using the conference call
phone number will be able to listen to
the meeting but will not be heard. If you
experience any technical problems with
the webcast or conference call, please
send an email to IACCPublicInquiries@
mail.nih.gov.
Individuals wishing to participate in
person or by using these electronic
services and who need special
assistance, such as captioning of the
conference call or other reasonable
accommodations, should submit a
request to the Contact Person listed on
this notice at least five days prior to the
meeting.
Security: In the interest of security,
NIH has instituted stringent procedures
for entrance onto the NIH campus. All
visitor vehicles, including taxicabs and
hotel and airport shuttles, will be
inspected before being allowed on
campus. Visitors will be asked to show
one form of identification (for example,
a government-issued photo ID, driver’s
license, or passport) and to state the
purpose of their visit. Also as a part of
security procedures, attendees should
be prepared to present a photo ID at the
meeting registration desk during the
check-in process. Pre-registration is
recommended. Seating will be limited
to the room capacity and seats will be
on a first come, first served basis, with
expedited check-in for those who are
pre-registered.
Meeting schedule subject to change.
Information about the IACC is
available on the Web site: https://
www.iacc.hhs.gov.
Dated: October 4, 2016.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–24409 Filed 10–7–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Office of the Director, Office of Science
Policy, Office of Biotechnology
Activities; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the meeting of the
National Science Advisory Board for
Biosecurity (NSABB).
Name of Committee: National Science
Advisory Board for Biosecurity.
VerDate Sep<11>2014
20:12 Oct 07, 2016
Jkt 241001
Date: November 4, 2016.
Time: 12:00 p.m.–3:00 p.m. Eastern.
Agenda: Presentations and discussions
regarding: (1) Stakeholder engagement on
implementation of the U.S. Government
Policy for Institutional Oversight of Life
Sciences Dual Use Research of Concern
(DURC); (2) status of the Blue Ribbon Panel
review of the 2014 variola virus incident on
the NIH Bethesda campus; and (3) other
business of the Board.
Place: National Institutes of Health, 6705
Rockledge Drive, Suite 750, Bethesda, MD
20892 (Telephone Conference call only; No
in-person meeting).
Call-in Information: U.S. Toll-Free Dial-In:
1 (888) 939–3921. Confirmation Number:
43519965.
Contact Person: Christopher Viggiani,
Ph.D., Executive Director, NSABB, NIH
Office of Science Policy, 6705 Rockledge
Drive, Suite 750, Bethesda, Maryland 20892,
(301) 496–9838, viggianic@od.nih.gov.
Under authority 42 U.S.C. 217a, Section
222 of the Public Health Service Act, as
amended, the Department of Health and
Human Services established the National
Science Advisory Board for Biosecurity
(NSABB) to provide advice regarding federal
oversight of dual use research—defined as
legitimate biological research that generates
information and technologies that could be
misused to pose a biological threat to public
health and/or national security.
The toll-free teleconference line will be
open to the public at 11:30 a.m. to allow time
for operator-assisted check-in. Persons
planning to participate in the teleconference
may also pre-register online via the link
provided below or by calling Palladian
Partners, Inc. (Contact: Ida Donner at 301–
273–2838). Pre-registration will close at 12:00
p.m. Eastern on November 1, 2016. After that
time, attendees may register their information
with the teleconference operator upon
dialing into the meeting. Individuals who
plan to participate and need special
assistance should submit a request to the
contact person listed on this notice by
October 28.
Meeting materials: The meeting agenda and
links to the online pre-registration will be
available at: https://osp.od.nih.gov/officebiotechnology-activities/biosecurity/nsabb/
nsabb-meetings-and-conferences. Please
check this Web site for updates.
Public Comments: Time will be allotted on
the agenda for the delivery of oral public
comments. Members of the public interested
in delivering prepared comments relevant to
the mission of the NSABB should indicate so
upon registration. Sign-up for delivering
prepared oral comments will be limited to
one per person or organization representative
per open comment period. Individual
comments will be time-limited to facilitate
broad participation from multiple speakers.
In addition, interested persons may file
written comments at any time with the Board
via an email sent to nsabb@od.nih.gov or by
regular mail sent to the Contact Person listed
on this notice. Written statements should
include the name, contact information, and
when applicable, the professional affiliation
of the interested person. Written comments
received by 12:00 p.m. Eastern on November
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
70125
1, 2016 will be relayed to the NSABB prior
to the teleconference meeting. Any written
comments received after this deadline will be
provided to the Board either before or after
the meeting, depending on the volume of
comments received and the time required to
process them in accordance with privacy
regulations and other applicable federal
policies.
Dated: October 4, 2016.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–24412 Filed 10–7–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Environmental
Health Sciences; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Board
of Scientific Counselors, NIEHS.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
NATIONAL INSTITUTE OF
ENVIRONMENTAL HEALTH
SCIENCES, including consideration of
personnel qualifications and
performance, and the competence of
individual investigators, the disclosure
of which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Board of Scientific
Counselors, NIEHS.
Date: November 13–15, 2016.
Closed: November 13, 2016, 7:00 p.m. to
10:00 p.m.
Agenda: To review and evaluate
programmatic and personnel issues.
Place: Doubletree Guest Suites, 2515
Meridian Parkway, Research Triangle Park,
NC 27713.
Open: November 14, 2016, 8:30 a.m. to
11:50 a.m.
Agenda: Scientific Presentations.
Place: Nat. Inst. of Environmental Health
Sciences, Building 101, Rodbell Auditorium,
E:\FR\FM\11OCN1.SGM
11OCN1
Agencies
[Federal Register Volume 81, Number 196 (Tuesday, October 11, 2016)]
[Notices]
[Pages 70124-70125]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-24409]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health (NIMH); Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of an Interagency
Autism Coordinating Committee (IACC or Committee) meeting.
The purpose of the IACC meeting is to discuss business, agency
updates, and issues related to autism spectrum disorder (ASD) research
and services activities. The Committee will discuss the 2016-2017
update of the IACC Strategic Plan. The meeting will be open to the
public and will be accessible by webcast and conference call.
Name of Committee: Interagency Autism Coordinating Committee
(IACC).
Type of meeting: Open Meeting.
Date: October 26, 2016.
Time: 9:00 a.m. to 5:00 p.m.* Eastern Time * Approximate end
time.
Agenda: To discuss business, updates, and issues related to ASD
research and services activities. The Committee will discuss updates
of the IACC Strategic Plan.
Place: National Institutes of Health , 31 Center Drive, Building
31, C Wing, 6th Floor, Conference Room 6, Bethesda, MD 20892.
Webcast Live: https://videocast.nih.gov.
Conference Call Access: Dial: 888-469-2037, Access code:
3353029.
Cost: The meeting is free and open to the public.
Registration: A registration web link will be posted on the IACC
Web site (www.iacc.hhs.gov) prior to the meeting. Pre-registration
is recommended to expedite check-in. Seating in the meeting room is
limited to room capacity and on a first come, first served basis.
Onsite registration will also be available.
Deadlines: Notification of intent to present oral comments:
Wednesday, October 12, 2016 by 5:00 p.m. ET.
Submission of written/electronic statement for oral comments:
Tuesday, October 18, 2016 by 5:00 p.m. ET.
Submission of written comments: Tuesday, October 18, 2016 by
5:00 p.m. ET.
For IACC Public Comment guidelines please see: https://iacc.hhs.gov/meetings/public-comments/guidelines/.
Access: Medical Center Metro Station (Red Line).
Contact Person: Ms. Angelice Mitrakas, Office of Autism Research
Coordination, National Institute of Mental Health, NIH, 6001
Executive Boulevard, Room 6182A, Bethesda, MD 20892-9669, Phone:
301-435-9269, Email: IACCPublicInquiries@mail.nih.gov.
Public Comments: Any member of the public interested in presenting
oral comments to the Committee must notify the Contact Person listed on
this notice by 5:00 p.m. ET on Wednesday, October 12, 2016, with their
request to present oral comments at the meeting, and a written/
electronic copy of the oral presentation/statement must be submitted by
5:00 p.m. ET on Tuesday, October 18,
A limited number of slots for oral comment are available, and in
order to ensure that as many different individuals are able to present
throughout the year as possible, any given individual only will be
permitted to present oral comments once per calendar year (2016). Only
one representative of an organization will be allowed to present oral
comments in any given meeting; other representatives of the same group
may provide written comments. If the oral comment session is full,
individuals who could not be accommodated are welcome to provide
written comments instead. Comments to be read or presented in the
meeting must not exceed 250 words or 3 minutes, but a longer version
may be submitted in writing for the record. Commenters going beyond the
250 word or 3 minute time limit in the meeting may be asked to conclude
immediately in order to allow other comments and presentations to
proceed on schedule.
Any interested person may submit written public comments to the
IACC prior to the meeting by emailing the comments to
IACCPublicInquiries@mail.nih.gov or by submitting comments at the web
link: https://iacc.hhs.gov/meetings/public-comments/submit/index.jsp by
5:00 p.m. ET on Tuesday, October 18, 2016. The comments should include
the name, address, telephone number, and when applicable, the business
or professional affiliation of the interested person. NIMH anticipates
written public comments received by 5:00 p.m. ET on Tuesday, October
18, 2016 will be presented to the Committee prior to the meeting for
the Committee's consideration. Any written comments received after the
5:00 p.m. ET, October 18, 2016 deadline through October 25, 2016 will
be provided to the Committee either before or after the meeting,
depending on the volume of comments received and the time required to
process them in accordance with privacy regulations and other
applicable Federal policies. All written public comments and oral
public comment statements received by the deadlines for both oral and
written public comments will be provided to the IACC for their
consideration and will become part of the public record. Attachments of
copyrighted publications are not permitted, but web links or citations
for any copyrighted works cited may be provided.
In the 2009 IACC Strategic Plan, the IACC listed the ``Spirit of
Collaboration'' as one of its core values, stating that, ``We will
treat others with respect, listen to diverse views with open minds,
discuss submitted public comments, and foster discussions where
participants can comfortably offer opposing opinions.'' In keeping with
this core value, the IACC and the NIMH Office of Autism Research
Coordination (OARC) ask that members of the public who provide public
comments or participate in meetings of the IACC also seek to treat
others with respect and consideration in their communications and
actions, even when discussing issues of genuine concern or
disagreement.
[[Page 70125]]
Remote Access: The meeting will be open to the public through a
conference call phone number and webcast live on the Internet. Members
of the public who participate using the conference call phone number
will be able to listen to the meeting but will not be heard. If you
experience any technical problems with the webcast or conference call,
please send an email to IACCPublicInquiries@mail.nih.gov.
Individuals wishing to participate in person or by using these
electronic services and who need special assistance, such as captioning
of the conference call or other reasonable accommodations, should
submit a request to the Contact Person listed on this notice at least
five days prior to the meeting.
Security: In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs and hotel and airport shuttles, will be inspected
before being allowed on campus. Visitors will be asked to show one form
of identification (for example, a government-issued photo ID, driver's
license, or passport) and to state the purpose of their visit. Also as
a part of security procedures, attendees should be prepared to present
a photo ID at the meeting registration desk during the check-in
process. Pre-registration is recommended. Seating will be limited to
the room capacity and seats will be on a first come, first served
basis, with expedited check-in for those who are pre-registered.
Meeting schedule subject to change.
Information about the IACC is available on the Web site: https://www.iacc.hhs.gov.
Dated: October 4, 2016.
Carolyn Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-24409 Filed 10-7-16; 8:45 am]
BILLING CODE 4140-01-P